Mesoblast Ltd Files August 2025 6-K Report
Ticker: MEOBF · Form: 6-K · Filed: Aug 27, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Aug 27, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory-filing, foreign-private-issuer
Related Tickers: MESO
TL;DR
MESO filed a 6-K on Aug 27, 2025, attaching a press release. Standard disclosure.
AI Summary
On August 27, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement made to the Australian Securities Exchange. This filing serves as a report for the month of August 2025, indicating Mesoblast Limited's ongoing compliance and disclosure activities.
Why It Matters
This filing provides an update on Mesoblast Limited's regulatory disclosures, which is important for investors to stay informed about the company's compliance and reporting activities.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- August 27, 2025 (date) — Filing date
- Australian Securities Exchange (company) — Exchange where announcement was made
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of August 2025.
What document is attached to this Form 6-K?
This Form 6-K attaches a new release announcement filed by Mesoblast Limited with the Australian Securities Exchange, incorporated as Exhibit 99.1.
Who is the Chief Executive Officer and Executive Director of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Where is Mesoblast Limited's principal executive office located?
Mesoblast Limited's principal executive offices are located at Level 38, 55 Collins Street, Melbourne 3000, Australia.
Does Mesoblast Limited file annual reports under Form 20-F or Form 40-F?
Mesoblast Limited indicates it files annual reports under Form 20-F.
Filing Stats: 212 words · 1 min read · ~1 pages · Grade level 17.1 · Accepted 2025-08-27 10:05:39
Filing Documents
- a2025-08x27webcastnotice.htm (6-K) — 15KB
- exhibit991.htm (EX-99.1) — 4KB
- exhibit991001.jpg (GRAPHIC) — 216KB
- exhibit991002.jpg (GRAPHIC) — 44KB
- 0001345099-25-000060.txt ( ) — 377KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated August 27, 2025 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated August 27, 2025.